HIV seroconversions in the PrEP impact trial

被引：0
|
作者：
Cartier, A. [1 ]
Milinkovic, A. [1 ]
Pereira, B. [1 ]
Reeves, I. [2 ]
Ogaz, D. [3 ]
Mitchell, H. [3 ]
Saunders, J. [3 ,4 ]
Charlett, A. [3 ]
Chiavenna, C. [3 ]
Sullivan, A.
机构：
[1] Chelsea & Westminster Hosp NHS Fdn Trust, London, England
[2] Homerton Healthcare NHS Fdn Trust, London, England
[3] UK Hlth Secur Agcy, London, England
[4] Cent & North West London NHS Fdn Trust, London, England
来源：
HIV MEDICINE | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
432
引用
收藏
页码：498 / 499
页数：2
相关论文
共 50 条
  • [21] Dried blood spot (DBS) and segmental hair analysis drug level testing to investigate HIV seroconversions in a PrEP programme with genotypic resistance to TD/FTC
    Clutterbuck, D.
    Gandhi, M.
    Templeton, K.
    Defechereux, P.
    Renwick, L.
    Anderson, P.
    Grant, R.
    HIV MEDICINE, 2019, 20 : 26 - 26
  • [22] HIV-PrEP
    Spornraft-Ragaller, P.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 10 - 11
  • [23] Preventing HIV With PrEP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (08): : 777 - 778
  • [24] The impact of pre-exposure prophylaxis (PrEP) and screening on the dynamics of HIV
    Pinto, Carla M. A.
    Carvalho, Ana R. M.
    JOURNAL OF COMPUTATIONAL AND APPLIED MATHEMATICS, 2018, 339 : 231 - 244
  • [25] Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia
    Sales, Jessica M.
    Cwiak, Carrie
    Haddad, Lisa B.
    Phillips, Ashley
    Powell, Leah
    Tamler, Ilyssa
    Sheth, Anandi N.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (04) : 414 - 418
  • [26] Acute facial neuralgia related to initiation of emtricitabine/tenofovir for HIV PrEP: a report of two cases in a PrEP demonstration trial
    Yin, Zhuoheng
    Tan, Rayner Kay Jin
    Tucker, Joseph D.
    Li, Quanmin
    Sherer, Renslow
    Li, Linghua
    Tang, Weiming
    SEXUAL HEALTH, 2024, 21 (01)
  • [27] Changes in Sexual Risk Behavior Among Participants in a PrEP HIV Prevention Trial
    Guest, Greg
    Shattuck, Dominick
    Johnson, Laura
    Akumatey, Betty
    Clarke, Edith Essie Kekawo
    Chen, Pai-Lien
    MacQueen, Kathleen M.
    SEXUALLY TRANSMITTED DISEASES, 2008, 35 (12) : 1002 - 1008
  • [28] Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria
    Peterson, Kristin
    Folayan, Morenike O.
    BIOETHICS, 2019, 33 (01) : 35 - 42
  • [29] Persistently high rates of sexually transmitted infections in the DISCOVER HIV PrEP trial
    Gorgos, L.
    Coll, J.
    Mallon, P.
    Morris, S.
    Shao, Y.
    Wong, P.
    Ebrahimi, R.
    Das, M.
    McCallister, S.
    Brainard, D. M.
    Carter, C. C.
    Brar, I.
    Prins, M.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 : 115 - 115
  • [30] The importance of PrEP persistence in preventing HIV infections on PrEP
    Spinelli, Matthew A.
    Laborde, Nicole
    Kinley, Patrick
    Whitacre, Ryan
    Scott, Hyman M.
    Walker, Nicole
    Liu, Albert Y.
    Gandhi, Monica
    Buchbinder, Susan P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (08)
12345